Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

siplizumab

A monoclonal immunoglobulin G1 antibody with potential antineoplastic activity. Siplizumab binds to CD2, a specific receptor found in T cells and NK cells, thereby triggering a host immune response that results in lysis of CD2+ cells, selective suppression of the immune system, and control of activated T cell growth.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-CD2 monoclonal antibody
Abbreviation:MEDI-507
Code name:MEDI-507
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search